WO2001002591A1 - Plants expressing δ6-desaturase genes and oils from these plants containing pufas and method for producing unsaturated fatty acids - Google Patents
Plants expressing δ6-desaturase genes and oils from these plants containing pufas and method for producing unsaturated fatty acids Download PDFInfo
- Publication number
- WO2001002591A1 WO2001002591A1 PCT/EP2000/006223 EP0006223W WO0102591A1 WO 2001002591 A1 WO2001002591 A1 WO 2001002591A1 EP 0006223 W EP0006223 W EP 0006223W WO 0102591 A1 WO0102591 A1 WO 0102591A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- organism
- fatty acids
- nucleic acid
- desaturase
- seq
- Prior art date
Links
- 108010037138 Linoleoyl-CoA Desaturase Proteins 0.000 title claims abstract description 78
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims abstract description 44
- 150000004670 unsaturated fatty acids Chemical class 0.000 title claims abstract description 44
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 20
- 239000003921 oil Substances 0.000 title description 14
- 238000000034 method Methods 0.000 claims abstract description 62
- 102100034544 Acyl-CoA 6-desaturase Human genes 0.000 claims abstract description 53
- 230000009261 transgenic effect Effects 0.000 claims abstract description 36
- 150000002632 lipids Chemical class 0.000 claims abstract description 32
- 241000196324 Embryophyta Species 0.000 claims description 113
- 150000007523 nucleic acids Chemical group 0.000 claims description 58
- 150000004665 fatty acids Chemical class 0.000 claims description 50
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 48
- 229930195729 fatty acid Natural products 0.000 claims description 48
- 239000000194 fatty acid Substances 0.000 claims description 48
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 41
- 241000233866 Fungi Species 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 19
- 241001465754 Metazoa Species 0.000 claims description 16
- 150000001413 amino acids Chemical class 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 16
- 229920001184 polypeptide Polymers 0.000 claims description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 15
- 241000195493 Cryptophyta Species 0.000 claims description 15
- 230000002255 enzymatic effect Effects 0.000 claims description 11
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 10
- 241000223782 Ciliophora Species 0.000 claims description 7
- 241000192700 Cyanobacteria Species 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 6
- 230000002068 genetic effect Effects 0.000 claims description 6
- 241000195887 Physcomitrella patens Species 0.000 claims description 4
- 239000002537 cosmetic Substances 0.000 claims description 4
- 241001464430 Cyanobacterium Species 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000014509 gene expression Effects 0.000 abstract description 88
- 230000001965 increasing effect Effects 0.000 abstract description 23
- 150000003626 triacylglycerols Chemical class 0.000 abstract description 17
- 239000010685 fatty oil Substances 0.000 abstract description 12
- 244000005700 microbiome Species 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 description 87
- 239000013598 vector Substances 0.000 description 47
- 239000012634 fragment Substances 0.000 description 34
- 108020004414 DNA Proteins 0.000 description 29
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 24
- 230000015572 biosynthetic process Effects 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 22
- 108020004707 nucleic acids Proteins 0.000 description 21
- 102000039446 nucleic acids Human genes 0.000 description 21
- 240000002791 Brassica napus Species 0.000 description 18
- 230000001105 regulatory effect Effects 0.000 description 18
- 102000004169 proteins and genes Human genes 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 15
- 239000013612 plasmid Substances 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 14
- 230000009466 transformation Effects 0.000 description 14
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 13
- 244000020518 Carthamus tinctorius Species 0.000 description 13
- 235000010469 Glycine max Nutrition 0.000 description 13
- 240000003480 Talinum paniculatum Species 0.000 description 13
- 125000003729 nucleotide group Chemical group 0.000 description 13
- 244000068988 Glycine max Species 0.000 description 12
- 241000208818 Helianthus Species 0.000 description 12
- 235000003222 Helianthus annuus Nutrition 0.000 description 12
- 239000002773 nucleotide Substances 0.000 description 12
- 239000002299 complementary DNA Substances 0.000 description 11
- 235000004431 Linum usitatissimum Nutrition 0.000 description 10
- 240000006240 Linum usitatissimum Species 0.000 description 10
- 235000009470 Theobroma cacao Nutrition 0.000 description 10
- 244000299461 Theobroma cacao Species 0.000 description 10
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 10
- 238000009396 hybridization Methods 0.000 description 10
- 238000010367 cloning Methods 0.000 description 9
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 9
- 239000013604 expression vector Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 240000007594 Oryza sativa Species 0.000 description 8
- 235000007164 Oryza sativa Nutrition 0.000 description 8
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 8
- 244000046052 Phaseolus vulgaris Species 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 8
- 235000009566 rice Nutrition 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 235000017060 Arachis glabrata Nutrition 0.000 description 7
- 244000105624 Arachis hypogaea Species 0.000 description 7
- 235000010777 Arachis hypogaea Nutrition 0.000 description 7
- 235000018262 Arachis monticola Nutrition 0.000 description 7
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 7
- 235000006008 Brassica napus var napus Nutrition 0.000 description 7
- 240000000385 Brassica napus var. napus Species 0.000 description 7
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 7
- 235000013162 Cocos nucifera Nutrition 0.000 description 7
- 244000060011 Cocos nucifera Species 0.000 description 7
- 235000001950 Elaeis guineensis Nutrition 0.000 description 7
- 244000127993 Elaeis melanococca Species 0.000 description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 description 7
- 240000005979 Hordeum vulgare Species 0.000 description 7
- 240000008042 Zea mays Species 0.000 description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 7
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 7
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 7
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 7
- 229960002733 gamolenic acid Drugs 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 235000020232 peanut Nutrition 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 6
- 241000219194 Arabidopsis Species 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 240000003183 Manihot esculenta Species 0.000 description 6
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 244000038559 crop plants Species 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 235000021588 free fatty acids Nutrition 0.000 description 6
- 230000004927 fusion Effects 0.000 description 6
- 108020001507 fusion proteins Proteins 0.000 description 6
- 102000037865 fusion proteins Human genes 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 230000008488 polyadenylation Effects 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 240000004355 Borago officinalis Species 0.000 description 5
- 235000007689 Borago officinalis Nutrition 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 244000299507 Gossypium hirsutum Species 0.000 description 5
- 241000235575 Mortierella Species 0.000 description 5
- 101710202365 Napin Proteins 0.000 description 5
- 108700008625 Reporter Genes Proteins 0.000 description 5
- 244000082988 Secale cereale Species 0.000 description 5
- 235000007238 Secale cereale Nutrition 0.000 description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 description 5
- 244000061456 Solanum tuberosum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 5
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 235000003441 saturated fatty acids Nutrition 0.000 description 5
- 150000004671 saturated fatty acids Chemical class 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000008685 targeting Effects 0.000 description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 235000007319 Avena orientalis Nutrition 0.000 description 4
- 244000075850 Avena orientalis Species 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- 240000007154 Coffea arabica Species 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 241000219823 Medicago Species 0.000 description 4
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 241000233639 Pythium Species 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 235000019714 Triticale Nutrition 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 235000016213 coffee Nutrition 0.000 description 4
- 235000013353 coffee beverage Nutrition 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 241000228158 x Triticosecale Species 0.000 description 4
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- 235000003880 Calendula Nutrition 0.000 description 3
- 240000001432 Calendula officinalis Species 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 3
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010068370 Glutens Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000003228 Lactuca sativa Nutrition 0.000 description 3
- 240000008415 Lactuca sativa Species 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- -1 Manganese, magnesium salts Chemical class 0.000 description 3
- 235000010804 Maranta arundinacea Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000907999 Mortierella alpina Species 0.000 description 3
- 108091092724 Noncoding DNA Proteins 0.000 description 3
- 101710163504 Phaseolin Proteins 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 235000004443 Ricinus communis Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 240000003768 Solanum lycopersicum Species 0.000 description 3
- 235000021536 Sugar beet Nutrition 0.000 description 3
- 235000012308 Tagetes Nutrition 0.000 description 3
- 241000736851 Tagetes Species 0.000 description 3
- 244000145580 Thalia geniculata Species 0.000 description 3
- 235000012419 Thalia geniculata Nutrition 0.000 description 3
- 235000009120 camo Nutrition 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 3
- 235000005607 chanvre indien Nutrition 0.000 description 3
- 229940088530 claforan Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 3
- 239000011487 hemp Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 235000014571 nuts Nutrition 0.000 description 3
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000021533 Beta vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- 101000972350 Bombyx mori Lebocin-4 Proteins 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 241000199913 Crypthecodinium Species 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 241000199914 Dinophyceae Species 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 2
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 2
- 101710089395 Oleosin Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000197220 Pythium insidiosum Species 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 241000233667 Saprolegnia Species 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 230000029918 bioluminescence Effects 0.000 description 2
- 238000005415 bioluminescence Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 150000002313 glycerolipids Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000004960 subcellular localization Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- 101710099475 3'-phosphoadenosine 5'-phosphate phosphatase Proteins 0.000 description 1
- 101710161460 3-oxoacyl-[acyl-carrier-protein] synthase Proteins 0.000 description 1
- SOWUYFYWTFVKPP-UHFFFAOYSA-N 4,4-dimethoxy-5h-1,3-oxazole Chemical class COC1(OC)COC=N1 SOWUYFYWTFVKPP-UHFFFAOYSA-N 0.000 description 1
- LBLSRDDHGILUJH-UHFFFAOYSA-N 4-(1h-indol-2-yl)butanoic acid Chemical compound C1=CC=C2NC(CCCC(=O)O)=CC2=C1 LBLSRDDHGILUJH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 102100039239 Amidophosphoribosyltransferase Human genes 0.000 description 1
- 108010039224 Amidophosphoribosyltransferase Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- 108050002233 Beta-ketoacyl synthases Proteins 0.000 description 1
- 102000011802 Beta-ketoacyl synthases Human genes 0.000 description 1
- 108020004256 Beta-lactamase Proteins 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- 102000016899 Cytochrome-B(5) Reductase Human genes 0.000 description 1
- 108010028689 Cytochrome-B(5) Reductase Proteins 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 102100034543 Fatty acid desaturase 3 Human genes 0.000 description 1
- 108010087894 Fatty acid desaturases Proteins 0.000 description 1
- 101710196411 Fructose-1,6-bisphosphatase Proteins 0.000 description 1
- 101710186733 Fructose-1,6-bisphosphatase, chloroplastic Proteins 0.000 description 1
- 101710109119 Fructose-1,6-bisphosphatase, cytosolic Proteins 0.000 description 1
- 101710198902 Fructose-1,6-bisphosphate aldolase/phosphatase Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000701109 Human adenovirus 2 Species 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 101150000102 LEB4 gene Proteins 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 101100396751 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ilv-2 gene Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108010019653 Pwo polymerase Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 101000912235 Rebecca salina Acyl-lipid (7-3)-desaturase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 240000004053 Rorippa indica Species 0.000 description 1
- 101100434411 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADH1 gene Proteins 0.000 description 1
- 101000877236 Siganus canaliculatus Acyl-CoA Delta-4 desaturase Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000192581 Synechocystis sp. Species 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 101150057897 USP gene Proteins 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 108700021044 acyl-ACP thioesterase Proteins 0.000 description 1
- 101150102866 adc1 gene Proteins 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical class N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 108010011713 delta-15 desaturase Proteins 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001030 gas--liquid chromatography Methods 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 108010050792 glutenin Proteins 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 108010002685 hygromycin-B kinase Proteins 0.000 description 1
- 101150045896 ilv-2 gene Proteins 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 230000037360 nucleotide metabolism Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 108090000021 oryzin Proteins 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 108060006613 prolamin Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 201000005484 prostate carcinoma in situ Diseases 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000008117 seed development Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000005758 transcription activity Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Definitions
- the present invention relates to an improved process for the production of unsaturated fatty acids and a process for the production of triglycerides with an increased content of unsaturated fatty acids.
- the invention relates to the production of a transgenic organism, preferably a transgenic plant or a transgenic microorganism with an increased content of fatty acids, oils or lipids with ⁇ 6 double bonds due to the expression of a ⁇ 6-desaturase from moss.
- the invention also relates to transgenic organisms which contain a ⁇ 6-desaturase gene, and to the use of the unsaturated fatty acids or triglycerides produced in the process with an increased content of unsaturated fatty acids.
- Fatty acids and triglycerides have a variety of uses in the food industry, animal nutrition, cosmetics and pharmaceuticals. Depending on whether it is free saturated or unsaturated fatty acids or triglycerides with an increased content of saturated or unsaturated fatty acids, they are suitable for a wide variety of applications, for example polyunsaturated fatty acids are added to baby food to increase the nutritional value.
- the various fatty acids and triglycerides are mainly obtained from microorganisms such as Mortierella or from oil-producing plants such as soybean, rapeseed, sunflower and others, where they are generally obtained in the form of their triacylglycerides. But they can also be obtained from animals such as fish.
- the free fatty acids are advantageously produced by saponification.
- oils with saturated or unsaturated fatty acids are preferred.
- lipids with unsaturated fatty acids especially polyunsaturated fatty acids, are preferred in human nutrition because they have a positive influence on the cholesterol level in the blood and thus on the possibility of heart disease.
- Unsaturated fatty acids are also said to have a positive effect on carcinogenesis. They are also important raw materials for the synthesis of compounds that are important biological processes within the Control the organism. They are therefore used in various diet foods or medications.
- WO 94/11516 claims a ⁇ 12 desaturase. ⁇ 6 desaturases are described in Girke et al. (The Plant Journal, 15, 1998: 39-48), Napier et al. (Biochem. J., 330, 1998: 611-614), Murata et al. (Biosynthesis of ⁇ -linolenic acid in cyanobacterium spirulina
- membrane-bound proteins are very difficult to isolate and characterize (McKeon et al., Methods in Enzymol. 71, 1981: 12141-12147, Wang et al., Plant Physiol. Biochem., 26, 1988: 777-792).
- membrane-bound desaturases are characterized by incorporation into one
- the object was therefore to provide a process for the production of unsaturated fatty acids using genes which code, for example, for desaturase enzymes and which are involved in the synthesis of polyunsaturated fatty acids in the seeds of an oilseed, and thus to increase the content of polyunsaturated fatty acids.
- This object was achieved by a process for the production of unsaturated fatty acids, characterized in that at least one isolated nucleic acid sequence which codes for a polypeptide with ⁇ -desaturase activity, selected from the group:
- the attracted organism is introduced into an organism, this organism is attracted, the attracted organism containing at least 1 mol% of unsaturated fatty acids based on the total fatty acid content in the organism.
- Cultivation of the organism is to be understood as the cultivation of plants as well as the cultivation of eukaryotic or prokaryotic microorganisms such as bacteria, yeasts, fungi, ciliates, algae, cyanobacteria, animal or plant cells or cell groups or the cultivation of animals.
- eukaryotic or prokaryotic microorganisms such as bacteria, yeasts, fungi, ciliates, algae, cyanobacteria, animal or plant cells or cell groups or the cultivation of animals.
- the organisms obtained in the process according to the invention generally contain unsaturated fatty acids in the form of bound fatty acids, that is to say the unsaturated fatty acids are predominantly in the form of their mono-, di- or triglycerides, glycolipids, lipoproteins or phospholipids such as oils or lipids or other fatty acids bound as esters or amides.
- Free fatty acids are also contained in the organisms in the form of the free fatty acids or in the form of their salts.
- the free or bound unsaturated fatty acids advantageously contain, compared to the starting organisms, an increased content of fatty acids with ⁇ 6 double bonds, such as ⁇ -linolenic acid.
- the organisms obtained by cultivation in the process according to the invention and the unsaturated fatty acids contained in them can be used directly, for example, for the production of pharmaceutical preparations, agrochemicals, animal feeds or foods or after isolation from the organisms. All stages of the purification of the unsaturated fatty acids can be used, ie from crude extracts of the fatty acids to completely purified fatty acids are suitable for the production of the aforementioned products.
- the bound fatty acids can be released from, for example, the oils or lipids, for example via basic hydrolysis, for example with NaOH or KOH. These free fatty acids can be used directly in the mixture obtained or after further purification for the production of pharmaceutical preparations, agrochemicals, animal feeds or foods.
- the bound or free fatty acids can also be used for transesterification or esterification, for example with other mono-, di- or triglycerides or glycerol, in order to increase the proportion of unsaturated fatty acids in these compounds, for example in the triglycerides.
- a further subject of the invention is a process for the production of triglycerides with an increased unsaturated fatty acid content by triglycerides with saturated or unsaturated or saturated and unsaturated fatty acids with at least one of the protein which is encoded by the sequence SEQ ID NO: 2 , incubated.
- the process is advantageously carried out in the presence of compounds which can absorb or give off reduction equivalents. The fatty acids can then be released from the triglycerides.
- organisms for the processes mentioned are plants such as arabidopsis, barley, wheat, rye, oats, corn, soybeans, rice, cotton, sugar beet, tea, carrots, peppers, canola, sunflower, flax, hemp, potatoes, triticale, tobacco, Tomato, rapeseed, coffee, tapioca, cassava, arrowroot, tagetes, alfalfa, peanut, castor bean, coconut, oil palm, safflower (Carthamus tinctorius), lettuce and the various tree, nut and wine species, or cocoa beans, microorganisms such as fungi Mortierella, Saprolegnia or Pythium, bacteria such as the genus Escherichia, cyanobacteria, algae or protozoa such as dinoflagellates such as Crypthecodinium.
- plants such as arabidopsis, barley, wheat, rye, oats, corn, soybeans, rice, cotton, sugar beet
- Organisms which can naturally synthesize oils in large quantities such as microorganisms such as fungi such as Mortierella alpina, Pythium insidiosum or plants such as soybean, rapeseed, coconut, oil palm, canola, safflower (Carthamus tinctorius), castor oil, calendula, linseed, borage, peanut, are preferred , Cocoa bean or sunflower, soya, rape or sunflower are particularly preferred.
- microorganisms such as Mortierella alpina, Pythium insidiosum or plants such as soybean, rapeseed, coconut, oil palm, canola, safflower (Carthamus tinctorius), castor oil, calendula, linseed, borage, peanut, are preferred , Cocoa bean or sunflower, soya, rape or sunflower are particularly preferred.
- Microorganisms such as bacteria, fungi, ciliates, plant or animal cells are usually in a liquid medium containing a carbon source mostly in the form of sugars, a nitrogen source mostly in the form of organic nitrogen sources such as yeast extract or salts such as ammonium sulfate, trace elements such as iron, Manganese, magnesium salts and possibly vitamins contains, at temperatures between 0 ° C and 100 ° C, preferably between 10 ° C to 60 ° C, depending on the organism, oxygen or in the absence of oxygen.
- the pH of the nutrient liquid can be kept at a fixed value, i.e.
- the pH is regulated during cultivation or the pH is not regulated and changes during cultivation.
- the cultivation can be batch-wise, semi-batch wise or continuous. Nutrients can be added at the start of the fermentation or fed semi-continuously or continuously. Cultivation on solid media is also possible.
- plants After transformation, plants are generally regenerated and then grown or grown as usual. This can be done in the greenhouse or outdoors.
- the lipids are usually obtained from the organisms.
- the organisms can first be digested after harvesting or used directly.
- the lipids are advantageously mixed with suitable solvents such as apolar
- Solvents such as hexane or ethanol, isopropanol or mixtures such as hexane / isopropanol, phenol / chloroform / isoamyl alcohol extracted at temperatures between 0 ° C to 80 ° C, preferably between 20 ° C to 50 ° C.
- the biomass is usually extracted with an excess of solvent, for example an excess of solvent to biomass of 1: 4.
- the solvent is then removed, for example by distillation.
- the extraction can also be carried out with supercritical CO 2 . After extraction, the remaining biomass can be removed, for example, by filtration.
- the crude oil obtained in this way can then be further purified, for example by removing turbidity by adding polar solvents such as acetone or chloroform and then filtering or centrifuging. Further purification using chromatographic processes, distillation or crystallization is also possible.
- Another object of the invention are unsaturated fatty acids and trigylcerides with an increased content of unsaturated fatty acids, which were prepared by the above methods, and their use for the production of food, animal feed, cosmetics or pharmaceuticals. For this purpose, they are added to the food, animal feed, cosmetics or pharmaceuticals in the usual amounts.
- a ⁇ 6-desaturase from moss in organisms such as fungi, bacteria, animals or plants, preferably fungi, bacteria and plants, particularly preferably in plants, very particularly preferably in oil crop plants such as rapeseed, canola, linseed, soybean, sunflower , Borage, castor, oil palm, safflower (Carthamus tinctorius), coconut, peanut or cocoa bean receive higher levels of unsaturated fatty acids such as ⁇ -linolenic acid.
- crops such as corn, wheat, rye, oats, triticale, rice, barley, alfalfa or bush plants (coffee, cocoa, tea) is also advantageous.
- the expression of a gene which codes for a ⁇ -6-desaturase from moss in the above-mentioned organisms enables contents of unsaturated fatty acids in the organisms of at least 1 mol%, preferably at least 3 mol%, particularly preferably at least 4 mol -%, very particularly preferably at least 5 mol% can be achieved.
- Derivatives are, for example, functional homologues of the enzymes encoded by SEQ ID NO: 1 or their enzymatic activity, that is to say enzymes which catalyze the same enzymatic reactions as those of SEQ ID NO: 1. These genes also enable advantageous production of unsaturated fatty acids with double bonds in the ⁇ 6 position. Below unsaturated fatty acids are double or polyunsaturated fatty acids which have double bonds, to understand. The double bonds can be conjugated or non-conjugated. The sequence mentioned in SEQ ID NO: 1 codes for an enzyme which has a ⁇ 6-desaturase activity.
- the enzyme ⁇ 6-desaturase according to the invention advantageously introduces a cis double bond in position C 6 ⁇ C into fatty acid residues of glycerolipids (see SEQ ID NO: 1).
- the enzyme also has a ⁇ 6-desaturase activity which advantageously only introduces a cis double bond in the 10 position Cg-C into fatty acid residues of glycerolipids.
- the enzyme with the sequence given in SEQ ID NO: 1, which is a monofunctional ⁇ 6 desaturase also has this activity.
- nucleic acid sequence (s) used in the method according to the invention can advantageously be used for the isolation of further genomic sequences via homology screening.
- the derivatives mentioned can be isolated, for example, from other organisms in eukaryotic organisms such as plants such as specifically mosses, dinoflagellates or fungi.
- derivatives or functional derivatives include
- allelic variants which have at least 50% homology at the derived amino acid level, advantageously at least 70% homology, preferably at least 80% homology, particularly preferably at least 85% homology, very particularly preferably 90% homology ,
- amino acid sequence derived from the nucleic acids mentioned can be found in sequence SEQ ID NO: 2.
- Homology means identity, that is, the amino acid sequences are at least
- sequences according to the invention are at least 65% homologous, preferably at least 70%, particularly preferably 75%, very particularly preferably at least 80%.
- allele variants comprise in particular functional variants which can be obtained by deleting, inserting or substituting nucleotides from the sequence shown in SEQ ID NO: 1, wherein the enzymatic activity of the derived synthesized proteins is retained.
- Such DNA sequences can be started from the DNA sequence described in SEQ ID NO: 1 or parts thereof
- Isolate sequences for example with conventional hybridization methods or the PCR technique, from other eukaryotes such as those mentioned above. These DNA sequences hybridize to the sequences mentioned under standard conditions. Short oligonucleotides, for example of the conserved regions, which can be determined by comparison with other desaturase genes in a manner known to the person skilled in the art, are advantageously used for the hybridization. The histidine box sequences are advantageously used. However, longer fragments of the nucleic acids according to the invention or the complete sequences can also be used for the hybridization. These standard conditions vary depending on the nucleic acid used: oligonucleotide, longer fragment or complete sequence or depending on the type of nucleic acid DNA or RNA used for the hybridization. For example, the melting temperatures for DNA: DNA hybrids are approx. 10 ° C lower than those of DNA: RNA hybrids of the same length.
- DNA hybrids are advantageously 0.1 ⁇ SSC and temperatures between approximately 20 ° C. to 45 ° C., preferably between approximately 30 ° C. to 45 ° C.
- RNA hybrids the hybridization conditions are advantageously 0.1 x SSC and temperatures between about 30 C C and 55 ° C, preferably between about 45 ° C to 55 ° C. These specified temperatures for the hybridization are, for example, calculated melting temperature values for a nucleic acid with a length of approx. 100 nucleotides and a G + C content of 50% in the absence of formamide.
- the experimental conditions for DNA hybridization are in relevant textbooks of genetics such as Sambrook et al. , "Molecular Cloning", Cold Spring Harbor Laboratory, 1989, and can be calculated according to formulas known to the person skilled in the art, for example depending on the length of the nucleic acids, the type of hybrid or the G + C content. The person skilled in the art can obtain further information on hybridization from the following textbooks: Ausubel et al.
- homologs of the sequence SEQ ID No: 1 are furthermore to be understood, for example, as eukaryotic homologs, shortened sequences, single-stranded DNA of the coding and non-coding DNA sequence or RNA of the coding and non-coding DNA sequence.
- homologs of the sequence SEQ ID NO: 1 are to be understood as derivatives such as promoter variants. These variants can be changed by one or more nucleotide exchanges, by insertion (s) and / or deletion (s), but without the functionality or effectiveness of the promoters being impaired. Furthermore, the effectiveness of the promoters can be increased by changing their sequence, or completely replaced by more effective promoters, including organisms of other species.
- Derivatives are also advantageously to be understood as variants whose nucleotide sequence in the range -1 to -2000 before the start codon has been changed such that the gene expression and / or the protein expression is changed, preferably increased. Derivatives are also to be understood as variants that were changed at the 3 'end.
- the nucleic acid sequences which code for a ⁇ 6-desaturase can be produced synthetically or obtained naturally or contain a mixture of synthetic and natural DNA components, and can consist of different heterologous ⁇ 6-desaturase gene segments from different organisms.
- synthetic nucleotide sequences with codons are generated which are preferred by the corresponding host organisms, for example plants. This usually leads to optimal expression of the heterologous genes.
- plant preferred codons can be determined from the highest protein frequency codons expressed in most interesting plant species.
- Corynebacterium glutamicum is given in: Wada et al. (1992) Nucleic Acids Res. 20: 2111 to 2118). Such experiments can be carried out using standard methods and are known to the person skilled in the art.
- Functionally equivalent sequences which code for the ⁇ 6-desaturase gene are those derivatives of the sequence according to the invention which, despite the differing nucleotide sequence, are still the desired ones Functions, that is, possess the enzymatic activity of the proteins.
- Functional equivalents thus include naturally occurring variants of the sequences described here, as well as artificial, for example chemical nucleotide sequences obtained by chemical synthesis and adapted to the codon use of a plant.
- artificial DNA sequences are suitable as long as, as described above, they impart the desired property, for example increasing the content of ⁇ 6 double bonds in fatty acids, oils or lipids in the plant by overexpression of the ⁇ 6 desaturase gene in crop plants.
- Such artificial DNA sequences can be determined, for example, by back-translating proteins constructed using molecular modeling, which have ⁇ 6-desaturase activity, or by in vitro selection. Possible techniques for the in vitro evolution of DNA to change or improve the DNA sequences are described in Patten, P.A. et al. , Current Opinion in Biotechnology 8, 724-733 (1997) or Moore, J.C. et al., Journal of Molecular Biology 272, 336-347 (1997).
- Coding DNA sequences which are obtained by back-translating a polypeptide sequence in accordance with the odon usage specific for the host plant are particularly suitable.
- the specific codon usage can easily be determined by a person skilled in plant genetic methods by computer evaluations of other, known genes of the plant to be transformed.
- Suitable equivalent nucleic acid sequences are sequences which code for fusion proteins, part of the fusion protein being a ⁇ 6-desaturase polypeptide or a functionally equivalent part thereof.
- the second part of the fusion protein can e.g. be another polypeptide with enzymatic activity or an antigenic polypeptide sequence that can be used to detect ⁇ 6-desaturase expression (e.g. mye-tag or his-tag).
- this is preferably a regulatory protein sequence, such as e.g. a signal sequence for the ER that directs the ⁇ 6-desaturase protein to the desired site of action.
- the ⁇ 6-desaturase genes can advantageously be combined in the method according to the invention with other genes of fatty acid biosynthesis.
- examples of such genes are acetyltransferases, further desaturases or elongases of unsaturated or saturated fatty acids as described in WO 00/12720.
- the combination with, for example, NADH cytochrome B5 reductases is advantageous, which can absorb or release reduction equivalents.
- proteins used in the method according to the invention are to be understood as proteins which contain an amino acid sequence shown in the sequence SEQ ID NO: 2 or a sequence obtainable therefrom by substitution, inversion, insertion or deletion of one or 5 more amino acid residues, the enzymatic activity of the protein shown in SEQ ID NO: 2 is retained or is not significantly reduced. Not significantly reduced is to be understood as meaning all enzymes which are still at least 10%, preferably 20%, particularly preferred
- amino acids can be replaced by those with similar physicochemical properties (space filling, basicity, hydrophobicity, etc.).
- arginine residues against lysine residues valine residues against isoleucine
- amino acids 15 residues or aspartic acid residues exchanged for glutamic acid residues.
- one or more amino acids can also be interchanged, added or removed in their order, or several of these measures can be combined with one another.
- Derivatives are also to be understood as functional equivalents which in particular also include natural or artificial mutations of an originally isolated sequence coding for ⁇ 6-desaturase, which furthermore show the desired function, that
- Mutations include substitutions, additions, deletions, exchanges or insertions of one or more nucleotide residues.
- the present invention also encompasses those nucleotide sequences which are obtained by modifying the ⁇ 6-desaturase nucleotide sequence. The aim of such a modification can e.g. further narrowing down the coding sequence contained therein or e.g. also be the insertion of further restriction enzyme interfaces.
- nucleic acid sequences used in the method according to the invention are advantageously inserted into an expression cassette for introduction into a host organism.
- the nucleic acid sequences can also be introduced directly into the host organism.
- the nucleic acid sequence can advantageously be, for example, a DNA or cDNA sequence. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a ⁇ 6-desaturase with the sequences described above and which give the host the ability to overproduce fatty acids, oils or lipids with double bonds in the ⁇ 6-position. These sequences can be of homologous or heterologous origin.
- These regulatory sequences are intended to enable targeted expression of the genes and protein expression. Depending on the host organism, this can mean, for example, that the gene is only expressed and / or overexpressed after induction, or that it is expressed and / or overexpressed immediately.
- these regulatory sequences are sequences to which inducers or repressors bind and thus regulate the expression of the nucleic acid.
- the natural regulation of these sequences may still be present before the actual structural genes and may have been genetically modified so that the natural regulation has been switched off and the expression of the genes increased.
- the gene construct can also have a simpler structure, that is to say no additional regulation signals have been inserted in front of the nucleic acid sequence or its derivatives, and the natural promoter with its regulation has not been removed. Instead, the natural regulatory sequence was mutated in such a way that regulation no longer takes place and / or gene expression is increased.
- the gene construct can also advantageously contain one or more so-called "enhancer sequences” functionally linked to the promoter, which enable increased expression of the nucleic acid sequence. Additional advantageous sequences, such as further regulatory elements or terminators, can also be inserted at the 3 'end of the DNA sequences.
- the regulatory sequences or factors can preferably have a positive influence on the gene expression of the introduced genes and thereby increase it.
- the regulatory elements can advantageously be strengthened at the transcription level by using strong transcription signals such as promoters and / or "enhancers".
- an increase in translation is also possible, for example, by improving the stability of the mRNA.
- promoters which can advantageously control the expression of foreign genes in organisms in plants or fungi are suitable as promoters in the expression cassette.
- a plant promoter or promoters which originate, for example, from a plant virus are preferably used.
- Advantageous regulatory sequences for the method according to the invention are, for example, in promoters such as cos, tac, trp, tet, trp-tet, lpp, lac, lpp-lac, lacl ⁇ - T7, T5, T3 -, gal-, trc-, ara-, SP6-, ⁇ -P R - or contained in the ⁇ -P L promoter, which are advantageously used in gram-negative bacteria.
- the expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous ⁇ 6-desaturase gene in the organisms can advantageously be controlled in the plants at a specific point in time.
- Such advantageous plant promoters are, for example, the PRPl promoter [Ward et al. , Plans. Mol. Biol. 22 (1993), 361-366], one which is inducible by benzenesulfonamide (EP 388186), one which is inducible by tetracycline (Gatz et al., (1992) Plant J. 2,397-404), one inducible by salicylic acid Promoter (WO 95/19443), an abscisic acid-inducible (EP335528) or an ethanol- or cyclohexanone-inducible (WO 93/21334) promoter.
- plant promoters are, for example, the promoter of the cytosolic FBPase from potato, the ST-LSI promoter from potato (Stockhaus et al., EMBO J. 8 (1989) 2445-245), the promoter of the phosphoribosyl pyrophosphate amidotransferase from Glycine max (see also Genbank Accession Number U87999) or a node-specific promoter as in EP 249676 can advantageously be used. Plant promoters which ensure expression in tissues or plant parts / organs in which fatty acid biosynthesis or its precursors take place, such as, for example, in the endosperm or in the developing embryo, are particularly advantageous.
- advantageous promoters which ensure seed-specific expression, such as, for example, the USP promoter or derivatives thereof, the LEB4 promoter, the phaseolin promoter or the napin promoter.
- the 5 and particularly advantageous USP promoter or its derivatives listed according to the invention mediate very early gene expression in seed development (Baeumlein et al., Mol Gen Genet, 1991, 225 (3): 459-67).
- Further advantageous seed-specific promoters that can be used for monocot and dicot plants are those for dicots
- suitable promoters such as Napingen promoter from rapeseed (US5, 608, 152), the oleosin promoter from Arabidopsis (WO98 / 45461), the phaseolin promoter from Phaseolus vulgaris (US5, 504, 200), the Bce4- Promoter from Brassica (W091 / 13980) or the legume B4 promoter (LeB4, Baeumlein
- promoters suitable for monocotyledons such as the promoters, the promoters of the barley Ipt2 or Iptl gene (WO95 / 15389 and WO95 / 23230) or the promoters of the barley Hordein gene, the rice glutelin gene, the rice oryzin gene, the rice prolamin gene, the wheat gliadin
- promoters are particularly preferred which ensure expression in tissues or parts of plants in which, for example, the biosynthesis of fatty acids, oils and lipids or their precursors takes place. Promoters that ensure seed-specific expression should be mentioned in particular.
- promoters such as that of the lpt2 or Iptl gene from barley (WO95 / 15389 and WO95 / 23230), which mediat
- the desaturase genes are advantageously used in the nucleic acid construct.
- DNA fragments can be manipulated in order to obtain a nucleotide sequence which is expediently read in the correct direction and which is equipped with a correct reading frame.
- adapters or linkers can be attached to the fragments.
- the promoter and the terminator regions can expediently in the transcription direction with a linker or polylinker which has one or more restriction sites for the
- the linker has 1 to 10, usually 1 to 8, preferably 2 to 6, restriction sites. In general, the linker has a size of less than 100 bp, often less than 60 bp, but at least 5 bp within the regulatory ranges.
- the promoter can be native or homologous as well as foreign or heterologous to the host organism, for example to the host plant.
- the expression cassette contains in the 5 '-3' transcription direction the promoter, a DNA sequence which codes for a ⁇ 6-desaturase gene used in the method according to the invention and a region for the transcriptional termination. Different termination areas are interchangeable.
- Preferred polyadenylation signals are plant polyadenylation signals, preferably those which essentially correspond to T-DNA polyadenylation signals from Agrobacterium tumefaciens, in particular gene 3 of T-DNA (octopine synthase) of the Ti plasmid pTiACH5 (Gielen et al., EMBO J. 3 (1984), 835 ff) or corresponding functional equivalents.
- An expression cassette is produced by fusing a suitable promoter with a suitable ⁇ 6-desaturase DNA sequence and a polyadenylation signal according to common recombination and cloning techniques, as described, for example, in T. Maniatis, E.F. Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Ber an and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, F.M. et al. , Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987).
- the DNA sequence coding for a ⁇ 6-desaturase from Phsyco-mitrella patens contains all the sequence features which are necessary in order to achieve a localization correct for the location of the fatty acid, lipid or oil biosynthesis. Therefore no further targeting sequences per se are necessary. However, such a localization can be desirable and advantageous and can therefore be artificially modified or reinforced, so that such fusion constructs are also a preferred advantageous embodiment of the invention.
- nucleic acid sequences coding for ⁇ 6-desaturase genes are advantageously cloned together with at least one reporter gene into an expression cassette which is introduced into the organism via a vector or directly into the genome. This reporter gene should be easy to detect via a
- an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and optionally further regulatory elements which are operatively linked to the coding sequence for the ⁇ 6-desaturase DNA sequence in between.
- An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can perform its function as intended in the expression of the coding sequence.
- the sequences preferred for the operative linkage are targeting sequences to ensure subcellular localization in plastids. But also targeting sequences to ensure subcellular localization in the mitochondrion, in the endoplasmic reticulum
- ER in the cell nucleus, in oil corpuscles or other compartments can be used if necessary, and translation enhancers such as the 5 'guiding sequence from the tobacco mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987), 8693- 8711).
- An expression cassette can contain, for example, a constitutive promoter (preferably the USP or Napin promoter), the gene to be expressed and the ER retention signal.
- the amino acid sequence KDEL lysine, aspartic acid, glutamic acid, leucine
- the expression cassette is advantageously inserted into a vector such as, for example, a plasmid, a phage or other DNA, which enables optimal expression of the genes in the host organism.
- Suitable plasmids are, for example, in E.
- Advantageous yeast vectors are, for example, 2 ⁇ M, pAG-1, YEp6, YEpl3 or pEMBLYe23.
- Examples of algae or plant promoters are pLGV23, pGHlac + , pBIN19, pAK2004, pVKH or pDH51 (see Schmidt, R. and Willmitzer, L., 1988).
- the above-mentioned vectors or derivatives of the above-mentioned vectors represent a small selection of the possible plasmids.
- vectors are also understood to mean all other vectors known to the person skilled in the art, such as phages, viruses such as SV40, CMV, baculovirus, adenovirus, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular DNA.
- phages viruses
- viruses such as SV40, CMV, baculovirus, adenovirus, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular DNA.
- viruses such as SV40, CMV, baculovirus, adenovirus, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular DNA.
- viruses such as SV40, CMV, baculovirus, adenovirus, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular DNA.
- the expression cassette according to the invention can also advantageously be
- nucleic acid sequence according to the invention can also be introduced into an organism on its own.
- nucleic acid sequence according to the invention can all be introduced into the organism together with a reporter gene in a single vector or each individual gene with a reporter gene in each vector or several genes together in different vectors, the different vectors can be introduced simultaneously or successively.
- the vector advantageously contains at least one copy of the nucleic acid sequences which code for a ⁇ 6-desaturase and / or the expression cassette.
- the plant expression cassette can be transformed into the transformation vector pRT ((a) Toepfer et al., 1993, Methods Enzymol., 217: 66-78; (b) Toepfer et al. 1987, Nucl. Acids. Res. 15: 5890 ff. ) to be built in.
- pRT transformation vector
- Fusion vectors used in prokaryotes frequently use inducible systems with and without fusion proteins or fusion oligopeptides, it being possible for these fusions to take place both at the N-terminal and at the C-terminal or other usable domains of a protein.
- Such fusion vectors usually serve: i.) To increase the expression rate of the RNA ii.) To increase the achievable protein synthesis rate, iii.) To increase the solubility of the protein, iv. ) or to simplify purification by means of a binding sequence which can be used for affinity chromatography.
- proteolytic cleavage sites are also introduced via fusion proteins, which enables a part of the fusion protein to be split off, also for purification.
- recognition sequences for Identifying proteases are, for example, factor Xa, thrombin and enterokinase.
- Typical advantageous fusion and expression vectors are pGEX [Pharmacia Biotech Ine; Smith, D.B. and Johnson, K.S. (1988) Gene 67: 31-40], pMAL (New England Biolabs, Beverly, MA) and pRIT5 (Pharmacia, Piscataway, NJ) which contains glutathione S-transferase (GST), maltose binding protein, or protein A.
- GST glutathione S-transferase
- E. coli expression vectors are pTrc
- vectors for use in yeast are pYepSecl (Baldari, et al., (1987) Embo J. 6: 229-234), pMFa (Kurjan and Herskowitz, (1982) Cell 30: 933-943), pJRY88 (Schultz et al., (1987) Gene 54: 113-123), and pYES derivatives (Invitrogen Corporation, San Diego, CA).
- Vectors for use in filamentous mushrooms are described in: van den Hondel, C.A.M.J.J. & Punt, P.J. (1991) "Gene transfer Systems and vector development for filamentous fungi, in: Applied Molecular Genetics of Fungi, J.F. Peberdy, et al., Eds., P. 1-28, Cambridge University Press: Cambridge.
- insect cell expression vectors can also be used advantageously, e.g. for expression in Sf 9 cells. These are e.g. the vectors of the pAc series (Smith et al. (1983) Mol. Cell Biol. 3: 2156-2165) and the pVL series (Lucklow and Summers (1989) Virology 170: 31-39).
- plant cells or algal cells can advantageously be used for gene expression.
- plant expression vectors can be found in Becker, D., et al. (1992) "New plant binary vectors with selectable markers located proximal to the left border", Plant Mol. Biol. 20: 1195-1197 or in Bevan, M.W. (1984) "Binary ⁇ gebbacte ium vectors for plant transformation", Nucl. Acid. Res. 12: 8711-8721.
- nucleic acid sequences coding for the ⁇ 6-desaturase can be expressed in mammalian cells.
- Examples of corresponding expression vectors are pCDM8 and pMT2PC mentioned in: Seed, B. (1987) Nature 329: 840 or Kaufman et al. (1987) EMBO J. 6: 187-195).
- promoters to be used are preferably of viral origin, such as promoters of the polyoma, adenovirus 2, cytomegalovirus or Simian virus 40.
- Others prokaryotic and eukaryotic expression systems are mentioned in chapters 16 and 17 in Sambrook et al. , Molecular Cloning: A Laboratory Manual. 2nd, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 5 1989.
- nucleic acids according to the invention can in principle be carried out by all methods known to the person skilled in the art.
- transformation The transfer of foreign genes into the genome of a plant is called transformation.
- the methods described for the transformation and regeneration of plants from 5 plant tissues or plant cells for transient or stable transformation are used. Suitable methods are protoplast transformation by polyethylene glycol-induced DNA uptake, the biolistic method with the gene cannon - the so-called particle bombardment method -, electroporation, the incubation of dry embryos in DNA-containing solution, microinjection and the gene transfer mediated by Agrobacterium.
- the methods mentioned are described, for example, in B. Jenes et al. , Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, edited by SD Kung and R. 5 Wu, Academy Press (1993) 128-143 and in Potrykus Annu. Rev.
- the construct to be expressed is preferably cloned into a vector which is suitable for transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 0 12 (1984) 8711).
- Agrobacteria transformed with such a vector can then be used in a known manner for transforming plants, in particular crop plants, such as tobacco plants, for example, by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
- the transformation of plants with Agrobacterium tumefaciens is described, for example, by Höfgen and Willmitzer in Nucl. Acid Res.
- Agrobacteria transformed with an expression vector as described above can also be used in a known manner to transform plants such as test plants such as Arabidopsis or crop plants such as cereals, corn, oats, rye, barley, wheat, soybeans, rice, cotton, sugar beet, canola, triticale, rice, Sunflower, flax, hemp, potato, tobacco, tomato, coffee, cocoa, tea, carrot, paprika, rapeseed, tapioca, cassava, arrowroot, tagetes, alfalfa, lettuce and the various tree, nut and wine species, especially oil containing crops such as soy, peanut, castor, borage, flax, sunflower,
- Canola, cotton, flax, rapeseed, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean can be used, e.g. by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
- the genetically modified plant cells can be regenerated using all methods known to the person skilled in the art. Appropriate methods can be found in the above-mentioned writings by S.D. Kung and R. Wu, Potrykus or Höfgen and Willmitzer can be found.
- all organisms which are able to synthesize fatty acids, especially unsaturated fatty acids or are suitable for the expression of recombinant genes are advantageously suitable as organisms or host organisms for the nucleic acids used, the expression cassette or the vector used.
- Examples include plants such as Arabidopsis, Asteraceae such as Calendula or crops such as soybean, peanut, castor oil, sunflower, maize, cotton, flax, rapeseed, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean, microorganisms such as fungi, for example the genus Mortierella, Saprolegnia or Pythium, bacteria such as the genus Escherichia, cyanobacteria, ciliates, Thrausto- or Schizichytria, algae or protozoa such as dinoplagellates such as Crypthecodinium.
- crops such as soybean, peanut, castor oil, sunflower, maize, cotton, flax, rapeseed, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean
- microorganisms such as fungi, for example the genus Mortierella, Saprolegnia or Pythium,
- Organisms which can naturally synthesize oils in large quantities such as fungi of the genera Mortierella or Pythium, such as Mortierella alpina, Pythium insidiosum, or plants, such as soybean, rapeseed, coconut, oil palm, color safflower, castor oil, calendula, peanut, cocoa bean or sunflower, are particularly preferred be soybean, rapeseed, sunflower, castor oil, or Mortierella Pythium.
- transgenic animals are also suitable as host organisms, for example C. elegans.
- Usable expression strains e.g. those which have a lower protease activity are described in: Gottesman, S., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, California (1990) 119-128.
- the expression of the ⁇ 6-desaturase gene can take place specifically in the leaves, in the seeds, in the tubers or in other parts of the plant.
- Such fatty acids, oils or lipids with ⁇ 6 double bonds overproducing transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
- a preferred object according to the invention is transgenic plants, for example crop plants such as corn, oats, rye, wheat, barley, corn, rice, soybeans, sugar beet, canola, triticale, sunflower, flax, hemp, tobacco, tomato, coffee, cocoa, tea, Carrot, bell pepper, rapeseed, tapioca, cassava, arrowroot, tagetes, alfalfa, lettuce and the various tree, nut and wine species, potato, in particular oil-containing crops, such as soybean, peanut, castor oil, borage, flax, sunflower, canola , Cotton, flax, rapeseed, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean, test plants such as Arabidopsis or other plants such as moss or algae containing a functional nucleic acid sequence according to the invention or a functional expression cassette.
- Functional means here that an enzymatically active enzyme is formed.
- the expression cassette or the nucleic acid sequences according to the invention containing a ⁇ 6-desaturase gene sequence can also be used to transform the above-mentioned organisms such as bacteria, cyanobacteria, filamentous fungi, ciliates, animals or algae with the aim of increasing the content of fatty acids, oils or lipids ⁇ 6 double bonds can be used.
- Preferred transgenic organisms are bacteria, cyanobacteria, filamentous fungi or algae.
- Transgenic organisms are understood to mean organisms which contain a foreign nucleic acid from another organism which codes for a ⁇ 6-desaturase used in the process according to the invention.
- Transgenic organisms are also understood to mean organisms which have a nucleic acid which comes from the same organism and which codes for a ⁇ 6-desaturase, whereby this nucleic acid is contained as an additional gene copy or is not contained in the natural nucleic acid environment of the ⁇ 6-desaturase gene.
- Transgenic organisms are also organisms in which the natural 3 'and / or 5' region of the ⁇ 6-desaturase gene has been changed by targeted genetic engineering changes compared to the parent organism.
- Transgenic organisms in which a foreign DNA has been introduced are preferred.
- Transgenic plants into which foreign DNA has been introduced are particularly preferred.
- Transgenic plants are understood to mean individual plant cells and their cultures, such as callus cultures on solid media or in liquid culture, plant parts and whole plants.
- transgenic organisms selected from the group of plants, fungi, ciliates, algae, bacteria, cyanobacteria or animals, preferably transgenic plants or algae, which contain at least one isolated nucleic acid sequence which codes for a polypeptide with ⁇ 6-desaturase activity from the group:
- ⁇ 6 double bonds mean, for example, the artificially acquired ability of an increased biosynthesis capacity through functional overexpression of the ⁇ 6-desaturase gene in the organisms according to the invention advantageously in the transgenic plants according to the invention compared to the non-genetically modified starting plants, at least for the duration of at least one plant generation.
- the biosynthesis site of fatty acids, oils or lipids is generally the seed or cell layers of the seed, so that a seed-specific expression of the ⁇ 6-desaturase gene is useful.
- biosynthesis of fatty acids, oils or lipids need not be limited to the seed tissue, but also in all other parts of the plant - for example in epidermal cells or in the tubers - tissue can take place specifically.
- constitutive expression of the exogenous ⁇ 6-desaturase gene is advantageous.
- inducible expression may also appear desirable.
- the effectiveness of the expression of the ⁇ 6-desaturase gene can be determined, for example, in vitro by proliferation of the shoot meristem.
- a change in the type and level of expression of the ⁇ 6-desaturase gene and its effect on the fatty acid, oil or lipid biosynthesis performance on test plants can be tested in greenhouse experiments.
- the invention relates to transgenic plants transformed with a nucleic acid sequence which codes for a ⁇ 6-desaturase, a vector or an expression cassette containing a ⁇ 6-desaturase gene sequence or DNA sequences which hybridize therewith, and transgenic cells, tissue , Parts and propagation material of such plants.
- Transgenic crop plants as described above are particularly preferred.
- Plants in the sense of the invention are mono- and dicotyledonous plants or algae.
- SEQ ID N0: 1 sequence or hybridizing DNA sequences for the production of fungi, bacteria, animals or plants, preferably plants with an increased content of fatty acids, oils or lipids with ⁇ 6 double bonds by expression of this ⁇ 6-desaturase DNA sequence in plants ,
- the cloning processes such as Restriction cleavage, agarose gel electrophoresis, purification of DNA fragments, transfer
- the sequencing of recombinant DNA molecules was carried out with a laser fluorescence DNA sequencer from ABI according to the method of Sanger (Sanger et al. (1977) Proc. Natl. Acad. Sci. USA74, 5463-5467). Fragments resulting from a polymerase chain reaction were sequenced and checked to avoid polymerase errors in constructs to be expressed.
- Example 3 Lipid analysis from the protonema of P. patens and from yeast cells
- Yeast cultures transformed with pYES2 (control) and pYESdelta ⁇ ( ⁇ 6-desaturase cDNA) were grown on uracil-dop-out medium with 2% raffinose and 1% tergitol NP-40 (for stabilizing the fatty acids).
- fatty acids were solubilized in 5% tergitol and added at a final concentration of 0.0003%. The results of the expression are shown in Table I.
- fatty acids with a double bond at position 6 is only possible in the presence of the expression construct with the ⁇ 6-desaturase cDNA.
- This ⁇ 6-desaturase enzyme has a greater activity towards fatty acids which already contain a double bond at position 9 or 12 (in relation to the carbon atom in the chain).
- the fatty acid methyl esters of the entire lipid of the yeast were analyzed by GC.
- the individual fatty acids synthesized are given in the table in mol% of the total fatty acids.
- Example 6 Isolation of ⁇ 6-desaturase cDNA and genomic 10 clones from P. patens
- fragments of a ⁇ 6-desaturase gene were cloned at 20 72 ° C., 5 min.
- poly (A) RNA was isolated from P. patens Protonema culture 12 days old. The PCR described above was carried out with this poly (A) RNA. Fragments of the expected fragment length (500 to 600 bp) were cloned into pUC18 and
- the nucleotide sequence is given in SEQ ID NO: 1.
- the deduced amino acid sequence can be found in SEQ ID NO: 2.
- the associated genomic sequence is given in SEQ ID NO: 1.
- Table II shows the results of the comparison between the new P. patens ⁇ 6-desaturase over the entire nucleic acid sequence with the following known ⁇ 6-desaturase: Borago officinalis (U79010), Synechocystis sp (L11421), Spirulina platensis 5 (X87094), Caenorhabiditis elegans ( AF031477), Mortierella alpina (WO 98/46764), Homo sapiens (Cho et al., J. Biol. Chem., 274, 1999: 471-477), Rattus norvegicus (AB021980) and Mus musculus (Cho et al., J. Biol.
- the genomic ⁇ 6-acyllipid desaturase from Physcomitrella patens was modified based on the published sequence (Girke et al., Plant J., 15, 1998: 39-48) by means of polymerase chain reaction and cloning, isolated and used for the method according to the invention.
- a desaturase fragment was first isolated using a polymerase chain reaction using two gene-specific primers and into which Girke et al. (see above) Desaturasegen described.
- Primer TG5 5 '- ccgctcgagcgaggttgttgtggagcggc and primer TG3: 5 ⁇ -ctgaaatagtcttgctcc-3'
- the promoter-desaturase fragment obtained was cloned into the vector pJH3 by terminating the plasmid pSK with Xhol, treatment with T4-DNA polymerase and PstI restriction.
- the vector BamHI was cut and the overhangs were filled in with Klenow enzyme and then cut again with PstI. It was created by ligation of the
- the expression cassette from pJH7 was cut with Bspl20l and Notl and cloned into the binary vector pRE.
- the plasmid pRE-Ppdes ⁇ was formed.
- the ⁇ 6-desaturase cDNA from P. patens according to the invention was used as a template in a PCR reaction. With the help of the oligonucleotides listed below, a BamHI restriction site before the start codon and three adenine nucleotides were introduced into the ⁇ 6-desaturase cDNA as consensus translation sequence for eukaryotes. A 1512 base pair fragment of the ⁇ 6-desaturase was amplified and sequenced.
- Pp-d6Desl 5 '- CC GGTACC aaaatggtattcgcgggcggtg -3'
- Pp-d6Desl 5 '- CC GGTACC ttaactggtggtagcatgct -3'
- reaction mixtures contained approx. 1 ng / micro 1 matrices
- DNA 0.5 UM of the oligonucleotides and, 200 ⁇ M deoxy nucleotides (Pharmacia), 50 mM KC1, 10 mM Tris-HCl (pH 8.3 at 25 ° C, 1.5 mM MgCl 2 > and 0.02 U / ⁇ l Pwo polymerase (Boehringer Mannheim) and are incubated in a PCR machine from Perkin Elmer with the following temperature program:
- Annealing temperature 50 ° C, 30 sec
- Elongation temperature 72 ° C, 90 sec
- the fragment of approximately 1.5 kB base pairs obtained was ligated into the vector pBluescript SK- (Stratagene) which had been cleaved with EcoRV and was available as BamHI fragment for further cloning.
- pBin-USP contains the BamHI fragment of the ⁇ 6-desaturase.
- pBin-USP is a derivative of the plasmid pBinl9.
- pBinUSP originated from pBinl9 by using pBinl9 [Bevan et al. (1980) Nucl. Acids Res. 12, 8711], a USP promoter was inserted as an EcoRI-BaMHI fragment.
- the polyadenylation signal is that of gene 3 of the T-DNA of the Ti plasmid pTiACH5 (Gielen et al., (1984) EMBO J.
- nucleotides 11749-11939 being isolated as a PvuII-HindIII fragment and after addition of Sphl -Linkers cloned to the PvuII interface between the SpHI-HindIII interface of the vector.
- the USP promoter corresponds to nucleotides 1-684 (Genbank Accession X56240), with part of the non-coding region of the USP gene being contained in the promoter.
- the 684 base pair promoter fragment was amplified using a commercially available T7 standard primer (Stratagene) and using a synthesized primer via a PCR reaction using standard methods (primer sequence: 5 '-GTCGACCCGCGGACTAGTG- GGCCCTCTAGACCCGGGGGATCC GGATCTGCTGGCTATGAA.
- the PCR fragment was cut with EcoRI / SalI and inserted into the vector pBin19 with OCS terminator.
- the plasmid called pBinUSP was created.
- a construct was created using the v-ATPase-cl promoter.
- the promoter was cloned as an EcoRI / Kpnl fragment into the plasmid pBinl9 with OCS terminator and the ⁇ 6-desaturase gene from P. patens between promoter and via BamHI Terminator advertises.
- the promoter corresponds to a 1153 base pair fragment from beta-Vulgaris (Plant Mol Biol, 1999, 39: 463-475).
- the construct was used to transform Arabidopsis thaliana and oilseed rape plants.
- Example 8 Generation of transgenic rape plants (modified after
- Petioles or hypocotyledons of freshly sprouted sterile rape plants were incubated in a petri dish with a 1:50 agrobacterial dilution for 5-10 minutes. This was followed by a 3-day incubation in the dark at 25 ° C. on 3MS medium with 0.8% Bacto agar. The cultivation was continued after 3 days with 16 hours of light / 8 hours of darkness and on a weekly basis on MS medium with 500 mg / 1 claforan (Cefotaxi e-sodium), 50 mg / 1 kanamycin, 20 ⁇ M benzylaminopurine ( BAP) and 1.6 g / 1 glucose continued. Growing shoots were transferred to MS medium with 2% sucrose, 250 mg / 1 Claforan and 0.8% Bacto agar. If no roots formed after three weeks, 2-indolebutyric acid was added to the medium as root for growth.
- 2-indolebutyric acid was added to the medium as root for growth.
- Regenerated shoots were obtained on 2MS medium with kanamycin and claforan, transferred to soil after rooting and after cultivation, grown in a climatic chamber or in a greenhouse for two weeks, brought to flower, ripe seeds were harvested and analyzed for ⁇ 6-desaturase expression using lipid analyzes. Lines with increased levels or double bonds at the ⁇ 6 position would be identified. In the stably transformed transgenic lines, which functionally expressed the transgene, an increased content of double bonds at the ⁇ 6 position was found in comparison to untransformed control plants.
- Example 8 Lipid extraction from seeds
- the plant material was first mechanically homogenized using mortars to make it more accessible for extraction.
- the cell sediment was hydrolyzed with 1 N methanolic sulfuric acid and 2% dimethoxypropane at 90 ° C. and the lipids were transmethylated.
- the resulting fatty acid methyl esters (FAME) were extracted into petroleum ether.
- the extracted FAME were analyzed by gas liquid chromatography with a capillary column (chrome pack, WCOT fused silica, CP-Wax-52 CB, 25 m, 0.32 mm) and a temperature gradient from 170 ° C to 240 ° C in 20 min and 5 min at 240 ° C analyzed.
- the identity of the fatty acid methyl ester was confirmed by comparison with corresponding FAME standards (Sigma).
- the identity and the position of the double bond could be determined by suitable chemical derivatization of the FAME mixtures e.g. to 4,4-dimethoxyoxazoline derivatives (Christie, 1997, in: Advances in Lipid Methodology, 4th edition: Christie, Oily Press, Dundee, 119-169, and 1998, gas chromatography-mass spectrometry method, lipids 33: 343- 353) can be further analyzed using GC-MS.
- the GC analyzes of the fatty acid methyl esters from the transgenic rapeseed, which expressed the ⁇ 6-desaturase in a seed-specific manner, are shown in Table III.
- the transgenic rapeseed has at least 4.95% ⁇ -linolenic acid in the seed.
- Table III shows the GC analyzes of the fatty acid methyl esters from mature, transgenic rapeseed which express ⁇ 6-desaturase in a seed-specific manner.
- the fatty acid composition is given in [mol%] of the total fatty acids. It should be noted that individual plants of the T2 generation, which were obtained from positively transformed and self-grown plants, contain up to 4.95% ⁇ -linolenic acid.
- Table III GC analyzes of the fatty acid methyl esters of rapeseed
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00952997A EP1190080A1 (en) | 1999-07-06 | 2000-07-04 | PLANTS EXPRESSING $g(D)6-DESATURASE GENES AND OILS FROM THESE PLANTS CONTAINING PUFAS AND METHOD FOR PRODUCING UNSATURATED FATTY ACIDS |
CA002378423A CA2378423A1 (en) | 1999-07-06 | 2000-07-04 | Plants expressing .delta.6-desaturase genes and oils from these plants containing pufas and method for producing unsaturated fatty acids |
US10/019,048 US8835715B1 (en) | 2000-06-30 | 2000-07-04 | Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids |
AU65607/00A AU776417B2 (en) | 1999-07-06 | 2000-07-04 | Plants expressing delta6-desaturase genes and oils from these plants containing pufas and method for producing unsaturated fatty acids |
US14/268,700 US9611441B2 (en) | 1999-07-06 | 2014-05-02 | Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34753199A | 1999-07-06 | 1999-07-06 | |
US09/347,531 | 1999-07-06 | ||
DE10030976A DE10030976A1 (en) | 2000-06-30 | 2000-06-30 | Production of unsaturated fatty acids, useful e.g. in nutrition, cosmetics or pharmaceuticals, in organisms transformed with Physcomitrella patens delta-6-desaturase nucleic acid |
DE10030976.3 | 2000-06-30 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US34753199A Continuation-In-Part | 1999-07-06 | 1999-07-06 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/019,048 A-371-Of-International US8835715B1 (en) | 2000-06-30 | 2000-07-04 | Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids |
US14/268,700 Continuation US9611441B2 (en) | 1999-07-06 | 2014-05-02 | Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001002591A1 true WO2001002591A1 (en) | 2001-01-11 |
Family
ID=26006195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/006223 WO2001002591A1 (en) | 1999-07-06 | 2000-07-04 | Plants expressing δ6-desaturase genes and oils from these plants containing pufas and method for producing unsaturated fatty acids |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1190080A1 (en) |
AU (1) | AU776417B2 (en) |
CA (1) | CA2378423A1 (en) |
WO (1) | WO2001002591A1 (en) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002057464A2 (en) * | 2001-01-19 | 2002-07-25 | Basf Plant Science Gmbh | Method for the expression of biosynthetic genes in plant seeds using multiple expression constructs |
GB2385852A (en) * | 2002-02-27 | 2003-09-03 | Rothamsted Ex Station | Delta 6-desaturases from Primulaceae |
WO2003093482A2 (en) * | 2002-04-29 | 2003-11-13 | Basf Plant Science Gmbh | Method for producing multiple unsaturated fatty acids in plants |
EP1527182A2 (en) * | 2002-03-01 | 2005-05-04 | BASF Plant Science GmbH | Process for the production of unsaturated fatty acids |
WO2005080578A2 (en) * | 2004-02-17 | 2005-09-01 | The University Of York | Desaturase enzymes |
US7700833B2 (en) | 2002-03-01 | 2010-04-20 | Cornell University | Process for the production of unsaturated fatty acids |
US7736884B2 (en) | 2004-06-04 | 2010-06-15 | Fluxome Sciences A/S | Metabolically engineered Saccharomyces cells for the production of polyunsaturated fatty acids |
US7807849B2 (en) | 2004-04-22 | 2010-10-05 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US7834250B2 (en) | 2004-04-22 | 2010-11-16 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
WO2010142522A2 (en) | 2009-06-08 | 2010-12-16 | Basf Plant Science Company Gmbh | Novel fatty acid elongation components and uses thereof |
WO2011006948A1 (en) | 2009-07-17 | 2011-01-20 | Basf Plant Science Company Gmbh | Novel fatty acid desaturases and elongases and uses thereof |
WO2011023800A1 (en) | 2009-08-31 | 2011-03-03 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis |
WO2011064181A1 (en) | 2009-11-24 | 2011-06-03 | Basf Plant Science Company Gmbh | Novel fatty acid desaturase and uses thereof |
WO2011064183A1 (en) | 2009-11-24 | 2011-06-03 | Basf Plant Science Company Gmbh | Novel fatty acid elongase and uses thereof |
WO2011161093A1 (en) | 2010-06-25 | 2011-12-29 | Basf Plant Science Company Gmbh | Acyltransferases and uses therof in fatty acid production |
DE112009001585T5 (en) | 2008-07-01 | 2012-02-23 | Basf Plant Science Gmbh | Promoters of Brassica napus for seed-specific gene expression |
WO2012052468A2 (en) | 2010-10-21 | 2012-04-26 | Basf Plant Science Company Gmbh | Novel fatty acid desaturases, elongases, elongation components and uses therof |
US8629195B2 (en) | 2006-04-08 | 2014-01-14 | Bayer Materialscience Ag | Production of polyurethane foams |
WO2014020533A2 (en) | 2012-08-03 | 2014-02-06 | Basf Plant Science Company Gmbh | Novel enzymes, enzyme components and uses thereof |
US8816111B2 (en) | 2012-06-15 | 2014-08-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
EP2821492A2 (en) | 2009-05-13 | 2015-01-07 | BASF Plant Science Company GmbH | Acyltransferases and uses thereof in fatty acid production |
US9718759B2 (en) | 2013-12-18 | 2017-08-01 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US9938486B2 (en) | 2008-11-18 | 2018-04-10 | Commonwealth Scientific And Industrial Research Organisation | Enzymes and methods for producing omega-3 fatty acids |
US10005713B2 (en) | 2014-06-27 | 2018-06-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position |
US10513717B2 (en) | 2006-08-29 | 2019-12-24 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of fatty acids |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021022A2 (en) * | 1994-12-30 | 1996-07-11 | Rhone-Poulenc Agrochimie | Production of gamma linolenic acid by a δ6-desaturase |
WO1998046764A1 (en) * | 1997-04-11 | 1998-10-22 | Calgene Llc | Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
WO1999027111A1 (en) * | 1997-11-24 | 1999-06-03 | University Of Bristol | Desaturase genes and their use |
-
2000
- 2000-07-04 AU AU65607/00A patent/AU776417B2/en not_active Ceased
- 2000-07-04 CA CA002378423A patent/CA2378423A1/en not_active Abandoned
- 2000-07-04 EP EP00952997A patent/EP1190080A1/en not_active Withdrawn
- 2000-07-04 WO PCT/EP2000/006223 patent/WO2001002591A1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021022A2 (en) * | 1994-12-30 | 1996-07-11 | Rhone-Poulenc Agrochimie | Production of gamma linolenic acid by a δ6-desaturase |
WO1998046764A1 (en) * | 1997-04-11 | 1998-10-22 | Calgene Llc | Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
WO1999027111A1 (en) * | 1997-11-24 | 1999-06-03 | University Of Bristol | Desaturase genes and their use |
Non-Patent Citations (3)
Title |
---|
GIRKE, T. ET AL.: "Identification of a novel delta-6-acyl-group desaturase by targeted gene disruption in Physcomitrella patens", THE PLANT JOURNAL, vol. 15, no. 1, July 1998 (1998-07-01), pages 39 - 48, XP000881712 * |
SAYANOVA, O. ET AL.: "Expression of a borage desaturase cDNA containing an N-terminal cytochrome b5 domain results in the accumulation of high levels of delta-6-desaturated fatty acids in transgenic tobacco", PROC.NATL.ACAD.SCI.USA, vol. 94, April 1997 (1997-04-01), pages 4211 - 4216, XP002099447 * |
SPERLING, P. ET AL.: "A bifunctional delta-6-fatty acyl acetylenase/desaturase from thr moss Ceratodon purpureus", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 267, June 2000 (2000-06-01), pages 3801 - 3811, XP000941309 * |
Cited By (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002057464A3 (en) * | 2001-01-19 | 2003-02-27 | Basf Plant Science Gmbh | Method for the expression of biosynthetic genes in plant seeds using multiple expression constructs |
WO2002057464A2 (en) * | 2001-01-19 | 2002-07-25 | Basf Plant Science Gmbh | Method for the expression of biosynthetic genes in plant seeds using multiple expression constructs |
GB2385852A (en) * | 2002-02-27 | 2003-09-03 | Rothamsted Ex Station | Delta 6-desaturases from Primulaceae |
EP1527182A2 (en) * | 2002-03-01 | 2005-05-04 | BASF Plant Science GmbH | Process for the production of unsaturated fatty acids |
EP1527182A4 (en) * | 2002-03-01 | 2005-12-21 | Basf Plant Science Gmbh | Process for the production of unsaturated fatty acids |
US7700833B2 (en) | 2002-03-01 | 2010-04-20 | Cornell University | Process for the production of unsaturated fatty acids |
US7893320B2 (en) | 2002-04-29 | 2011-02-22 | Basf Plant Science Gmbh | Method for producing multiple unsaturated fatty acids in plants |
WO2003093482A2 (en) * | 2002-04-29 | 2003-11-13 | Basf Plant Science Gmbh | Method for producing multiple unsaturated fatty acids in plants |
WO2003093482A3 (en) * | 2002-04-29 | 2004-11-04 | Basf Plant Science Gmbh | Method for producing multiple unsaturated fatty acids in plants |
WO2005080578A2 (en) * | 2004-02-17 | 2005-09-01 | The University Of York | Desaturase enzymes |
WO2005080578A3 (en) * | 2004-02-17 | 2006-04-27 | Univ York | Desaturase enzymes |
US10781463B2 (en) | 2004-04-22 | 2020-09-22 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US8106226B2 (en) | 2004-04-22 | 2012-01-31 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US11597953B2 (en) | 2004-04-22 | 2023-03-07 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US11220698B2 (en) | 2004-04-22 | 2022-01-11 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US7807849B2 (en) | 2004-04-22 | 2010-10-05 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US8853432B2 (en) | 2004-04-22 | 2014-10-07 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US7932438B2 (en) | 2004-04-22 | 2011-04-26 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9453183B2 (en) | 2004-04-22 | 2016-09-27 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US10443079B2 (en) | 2004-04-22 | 2019-10-15 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US8071341B2 (en) | 2004-04-22 | 2011-12-06 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9994880B2 (en) | 2004-04-22 | 2018-06-12 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US7834250B2 (en) | 2004-04-22 | 2010-11-16 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9458410B2 (en) | 2004-04-22 | 2016-10-04 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US8158392B1 (en) | 2004-04-22 | 2012-04-17 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9970033B2 (en) | 2004-04-22 | 2018-05-15 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US9963723B2 (en) | 2004-04-22 | 2018-05-08 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9951357B2 (en) | 2004-04-22 | 2018-04-24 | Commonweatlh Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US9926579B2 (en) | 2004-04-22 | 2018-03-27 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US7736884B2 (en) | 2004-06-04 | 2010-06-15 | Fluxome Sciences A/S | Metabolically engineered Saccharomyces cells for the production of polyunsaturated fatty acids |
US8629195B2 (en) | 2006-04-08 | 2014-01-14 | Bayer Materialscience Ag | Production of polyurethane foams |
US10513717B2 (en) | 2006-08-29 | 2019-12-24 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of fatty acids |
DE112009001585T5 (en) | 2008-07-01 | 2012-02-23 | Basf Plant Science Gmbh | Promoters of Brassica napus for seed-specific gene expression |
EP2826864A2 (en) | 2008-07-01 | 2015-01-21 | BASF Plant Science GmbH | Promoters from Brassica napus for seed specific gene expression |
US9938486B2 (en) | 2008-11-18 | 2018-04-10 | Commonwealth Scientific And Industrial Research Organisation | Enzymes and methods for producing omega-3 fatty acids |
EP2821492A2 (en) | 2009-05-13 | 2015-01-07 | BASF Plant Science Company GmbH | Acyltransferases and uses thereof in fatty acid production |
WO2010142522A2 (en) | 2009-06-08 | 2010-12-16 | Basf Plant Science Company Gmbh | Novel fatty acid elongation components and uses thereof |
US8993841B2 (en) | 2009-06-08 | 2015-03-31 | Basf Plant Science Company Gmbh | Fatty acid elongation components and uses thereof |
DE112010002353T5 (en) | 2009-06-08 | 2012-08-09 | Basf Plant Science Company Gmbh | NEW FATTY ACID ELONGATION COMPONENTS AND APPLICATIONS THEREOF |
DE112010002967T5 (en) | 2009-07-17 | 2012-10-11 | Basf Plant Science Company Gmbh | New fatty acid desaturases and -elongases and applications thereof |
WO2011006948A1 (en) | 2009-07-17 | 2011-01-20 | Basf Plant Science Company Gmbh | Novel fatty acid desaturases and elongases and uses thereof |
WO2011023800A1 (en) | 2009-08-31 | 2011-03-03 | Basf Plant Science Company Gmbh | Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis |
EP3418387A1 (en) | 2009-08-31 | 2018-12-26 | Basf Plant Science Company GmbH | Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis |
EP3121283A1 (en) | 2009-08-31 | 2017-01-25 | BASF Plant Science Company GmbH | Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis |
EP3178937A1 (en) | 2009-08-31 | 2017-06-14 | BASF Plant Science Company GmbH | Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis |
WO2011064183A1 (en) | 2009-11-24 | 2011-06-03 | Basf Plant Science Company Gmbh | Novel fatty acid elongase and uses thereof |
WO2011064181A1 (en) | 2009-11-24 | 2011-06-03 | Basf Plant Science Company Gmbh | Novel fatty acid desaturase and uses thereof |
WO2011161093A1 (en) | 2010-06-25 | 2011-12-29 | Basf Plant Science Company Gmbh | Acyltransferases and uses therof in fatty acid production |
WO2012052468A2 (en) | 2010-10-21 | 2012-04-26 | Basf Plant Science Company Gmbh | Novel fatty acid desaturases, elongases, elongation components and uses therof |
US9458477B2 (en) | 2010-10-21 | 2016-10-04 | Basf Plant Science Company Gmbh | Fatty acid desaturases, elongases, elongation components and uses thereof |
DE112011103527T5 (en) | 2010-10-21 | 2013-10-17 | Basf Plant Science Company Gmbh | New fatty acid desaturases, elongases, elongation components and applications thereof |
EP2695936A1 (en) | 2010-10-21 | 2014-02-12 | BASF Plant Science Company GmbH | Novel fatty acid desaturases and uses thereof |
US9556102B2 (en) | 2012-06-15 | 2017-01-31 | Commonwealth Scientific And Industrial Research Organisation | Process for producing ethyl esters of polyunsaturated fatty acids |
US9932289B2 (en) | 2012-06-15 | 2018-04-03 | Commonwealth Scientific And Industrial Research Ogranisation | Process for producing ethyl esters of polyunsaturated fatty acids |
US8946460B2 (en) | 2012-06-15 | 2015-02-03 | Commonwealth Scientific And Industrial Research Organisation | Process for producing polyunsaturated fatty acids in an esterified form |
US8816111B2 (en) | 2012-06-15 | 2014-08-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
US9550718B2 (en) | 2012-06-15 | 2017-01-24 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
US10335386B2 (en) | 2012-06-15 | 2019-07-02 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
WO2014020533A2 (en) | 2012-08-03 | 2014-02-06 | Basf Plant Science Company Gmbh | Novel enzymes, enzyme components and uses thereof |
US9718759B2 (en) | 2013-12-18 | 2017-08-01 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US9725399B2 (en) | 2013-12-18 | 2017-08-08 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising long chain polyunsaturated fatty acids |
US10190073B2 (en) | 2013-12-18 | 2019-01-29 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising long chain polyunsaturated fatty acids |
US10800729B2 (en) | 2013-12-18 | 2020-10-13 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising long chain polyunsaturated fatty acids |
US10125084B2 (en) | 2013-12-18 | 2018-11-13 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US11623911B2 (en) | 2013-12-18 | 2023-04-11 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US10793507B2 (en) | 2014-06-27 | 2020-10-06 | Commonwealth Scientific And Industrial Research Organisation | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the SN-2 position |
US10005713B2 (en) | 2014-06-27 | 2018-06-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position |
Also Published As
Publication number | Publication date |
---|---|
AU776417B2 (en) | 2004-09-09 |
EP1190080A1 (en) | 2002-03-27 |
AU6560700A (en) | 2001-01-22 |
CA2378423A1 (en) | 2001-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60309136T2 (en) | DELTA 6-DESATURASE FROM PRIMULACAEA, PLANTS, EXPRESSIVE PLANTS, AND OILS THAT CONTAIN MULTIPLE UNSATURATED FATTY ACIDS | |
EP1613744B1 (en) | Delta-4 desaturases from euglena gracilis, expressing plants, and oils containing pufa | |
EP1181373B1 (en) | Delta6-acetylenase and delta6-desaturase from ceratodon purpureus | |
WO2001002591A1 (en) | Plants expressing δ6-desaturase genes and oils from these plants containing pufas and method for producing unsaturated fatty acids | |
EP1599582B1 (en) | Method for the production of polyunsaturated fatty acids | |
EP2180046B1 (en) | Method for producing polyunsaturated long-chain fatty acids in transgenic organisms | |
EP1356067B1 (en) | Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs | |
DE10219203A1 (en) | Process for the production of polyunsaturated fatty acids in plants | |
EP1945775B1 (en) | Method for the production of gamma-linolenic acid and/or stearidonic acid in transgenic brassicaceae and linaceae | |
DE10102338A1 (en) | New expression cassette for plant genes, useful for preparing transgenic plants that have increased production of polyunsaturated fatty acids | |
EP2046960A1 (en) | Process for producing arachidonic acid and/or eicosapentaenoic acid in plants | |
CN101238216A (en) | Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants | |
US9611441B2 (en) | Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids | |
DE19962409A1 (en) | Nucleic acid encoding delta6-acetylenase or desaturase, useful for producing plant oils with increased content of unsaturated fatty acids | |
DE10205607A1 (en) | New nucleic acid encoding fatty acid elongase, useful for producing polyunsaturated fatty acids as oils, lipids or free fatty acids | |
WO2004007732A1 (en) | Cloning and characterization of a lipoxygenase from phaeodactylum tricornutum | |
DE10203713A1 (en) | New nucleic acid encoding fatty acid elongase, useful for producing polyunsaturated fatty acids as oils, lipids or free fatty acids | |
DE10023893A1 (en) | New elongase gene extends 16, 18 and 20 carbon fatty acids, useful to manipulate plants to produce polyunsaturated fatty acids for the foodstuffs, cosmetics and pharmaceutical industries | |
DE102004017518A1 (en) | Preparing unsaturated fatty acid derivatives, for use e.g. as pharmaceuticals and cosmetics, in seeds of transgenic plants, comprises growing plants that contain specific elongase and desaturase genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10019048 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000952997 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2378423 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 65607/00 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2000952997 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWG | Wipo information: grant in national office |
Ref document number: 65607/00 Country of ref document: AU |